Merck, Moderna's Personalized Cancer Vaccine Shows Promise in Late-Stage Trial

Melanoma accounts for 1% of skin cancers but causes the majority of skin cancer deaths, with most recurrences happening within 2-3 years post-treatment.

• ?When will the full data be presented at an international medical meeting?
• ?Timeline for regulatory approval submissions in the U.S.